Nektar Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results
Go back to Nektar Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 68.36 +0.98 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.38 | 52 Week High | $19.98 | |||
| Open | $67.95 | 52 Week Low | $10.52 | |||
| Day High | $69.51 | P/E | N/A | |||
| Day Low | $67.34 | EPS | $-1.45 | |||
| Volume | 1,264,199 | |||||
